Tracking of Tumor Cell-Derived Extracellular Vesicles In Vivo Reveals a Specific Distribution Pattern with Consecutive Biological Effects on Target Sites of Metastasis.


Journal

Molecular imaging and biology
ISSN: 1860-2002
Titre abrégé: Mol Imaging Biol
Pays: United States
ID NLM: 101125610

Informations de publication

Date de publication:
12 2020
Historique:
received: 12 05 2020
accepted: 21 07 2020
revised: 16 07 2020
pubmed: 2 8 2020
medline: 6 8 2021
entrez: 2 8 2020
Statut: ppublish

Résumé

Extracellular vesicles, small vesicles carrying inter alia proteins, miRNA and RNA, are important mediators of intercellular communication. The purpose of this study was to assess the distribution of extracellular vesicles from highly malignant breast cancer and their subsequent effect on the immune cell infiltrate in target organs of metastasis. Extracellular vesicles were isolated from the tissue culture supernatant of highly malignant 4T1 breast cancer cells or the serum of healthy BALB/c mice. The purity of the isolate was verified by electron microscopy and western blotting. Extracellular vesicles were additionally subjected to proteome analysis. After labeling with the fluorescent dye DiR, extracellular vesicles were injected into healthy BALB/c mice and their in vivo distribution was assessed using fluorescence reflectance imaging (FRI). Following ex vivo imaging of the organs, lung tissue samples were analyzed for extracellular vesicle-mediated changes of myeloid cells and T cell numbers, using flow cytometry. Proteome analysis revealed major differences in the cargo of tumor cell-derived versus extracellular vesicles from healthy serum. In contrast to control extracellular vesicles, DiR-labeled extracellular vesicles from tumor cells preferentially accumulated in lung, liver, and spine. Subsequent flow cytometry of the immune cell composition of lung tissue samples revealed an increase of cytotoxic CD8+ T cells and a decrease of CD4+ T-helper cells as well as an increase in mature macrophages in response to tumor cell EV. In conclusion, distribution of tumor cell-derived extracellular vesicles follows a specific pattern and can be monitored, using dedicated imaging. Extracellular vesicles alter the immune cell composition in target organs of metastasis, using a specific proteome cargo.

Identifiants

pubmed: 32737655
doi: 10.1007/s11307-020-01521-9
pii: 10.1007/s11307-020-01521-9
pmc: PMC7666295
doi:

Substances chimiques

Proteome 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1501-1510

Références

Mashouri L, Yousefi H, Aref AR, Ahadi AM, Molaei F, Alahari SK (2019) Exosomes: composition, biogenesis, and mechanisms in cancer metastasis and drug resistance. Mol Cancer 18(1):75
doi: 10.1186/s12943-019-0991-5
Li I, Nabet BY (2019) Exosomes in the tumor microenvironment as mediators of cancer therapy resistance. Mol Cancer 18(1):32
doi: 10.1186/s12943-019-0975-5
Xu R, Rai A, Chen M, Suwakulsiri W, Greening DW, Simpson RJ (2018) Extracellular vesicles in cancer - implications for future improvements in cancer care. Nat Rev Clin Oncol 15(10):617–638
doi: 10.1038/s41571-018-0036-9
Zhang Y, Liu Y, Liu H, Tang WH (2019) Exosomes: biogenesis, biologic function and clinical potential. Cell Biosci 9:19
doi: 10.1186/s13578-019-0282-2
Doglioni G, Parik S, Fendt SM (2019) Interactions in the (pre)metastatic niche support metastasis formation. Front Oncol 9:219
doi: 10.3389/fonc.2019.00219
Guo Y, Ji X, Liu J, Fan D, Zhou Q, Chen C, Wang W, Wang G, Wang H, Yuan W et al (2019) Effects of exosomes on pre-metastatic niche formation in tumors. Mol Cancer 18(1):39
doi: 10.1186/s12943-019-0995-1
Peinado H, Aleckovic M, Lavotshkin S, Matei I, Costa-Silva B, Moreno-Bueno G, Hergueta-Redondo M, Williams C, Garcia-Santos G, Ghajar C et al (2012) Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med 18(6):883–891
doi: 10.1038/nm.2753
Costa-Silva B, Aiello NM, Ocean AJ, Singh S, Zhang H, Thakur BK, Becker A, Hoshino A, Mark MT, Molina H et al (2015) Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver. Nat Cell Biol 17(6):816–826
doi: 10.1038/ncb3169
Keklikoglou I, Cianciaruso C, Guc E, Squadrito ML, Spring LM, Tazzyman S, Lambein L, Poissonnier A, Ferraro GB, Baer C et al (2019) Chemotherapy elicits pro-metastatic extracellular vesicles in breast cancer models. Nat Cell Biol 21(2):190–202
doi: 10.1038/s41556-018-0256-3
Muller L, Hong CS, Stolz DB, Watkins SC, Whiteside TL (2014) Isolation of biologically-active exosomes from human plasma. J Immunol Methods 411:55–65
doi: 10.1016/j.jim.2014.06.007
Renart J, Reiser J, Stark GR (1979) Transfer of proteins from gels to diazobenzyloxymethyl-paper and detection with antisera: a method for studying antibody specificity and antigen structure. Proc Natl Acad Sci U S A 76(7):3116–3120
doi: 10.1073/pnas.76.7.3116
Konig S, Hadrian K, Schlatt S, Wistuba J, Thanos S, Bohm MRR (2019) Topographic protein profiling of the age-related proteome in the retinal pigment epithelium of Callithrix jacchus with respect to macular degeneration. J Proteome 191:1–15
doi: 10.1016/j.jprot.2018.05.016
Babicki S, Arndt D, Marcu A, Liang Y, Grant JR, Maciejewski A, Wishart DS (2016) Heatmapper: web-enabled heat mapping for all. Nucleic Acids Res 44(W1):W147–W153
doi: 10.1093/nar/gkw419
Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13(11):2498–2504
doi: 10.1101/gr.1239303
Gao K, Jin J, Huang C, Li J, Luo H, Li L, Huang Y, Jiang Y (2019) Exosomes derived from septic mouse serum modulate immune responses via exosome-associated cytokines. Front Immunol 10:1560
doi: 10.3389/fimmu.2019.01560
Patel GK, Khan MA, Zubair H, Srivastava SK, Khushman M, Singh S, Singh AP (2019) Comparative analysis of exosome isolation methods using culture supernatant for optimum yield, purity and downstream applications. Sci Rep 9(1):5335
doi: 10.1038/s41598-019-41800-2
Liu Y, Cao X (2016) Characteristics and significance of the pre-metastatic niche. Cancer Cell 30(5):668–681
doi: 10.1016/j.ccell.2016.09.011
Chen Q, Massague J (2012) Molecular pathways: VCAM-1 as a potential therapeutic target in metastasis. Clin Cancer Res 18(20):5520–5525
doi: 10.1158/1078-0432.CCR-11-2904
Lang B, Guerrero-Giménez ME, Prince TL, Ackerman A, Bonorino C, Calderwood SK (2019) Heat Shock Proteins Are Essential Components in Transformation and Tumor Progression: Cancer Cell Intrinsic Pathways and Beyond. Int J Mol Sci 20(18):4507. https://doi.org/10.3390/ijms20184507
Ruan J, Song H, Li C, Bao C, Fu H, Wang K, Ni J, Cui D (2012) DiR-labeled embryonic stem cells for targeted imaging of in vivo gastric cancer cells. Theranostics 2(6):618–628
doi: 10.7150/thno.4561
Meng F, Wang J, Ping Q, Yeo Y (2018) Quantitative assessment of nanoparticle biodistribution by fluorescence imaging, Revisited. ACS Nano 12(7):6458–6468
doi: 10.1021/acsnano.8b02881
Ezzat T, Dhar DK, Malago M, Olde Damink SW (2012) Dynamic tracking of stem cells in an acute liver failure model. World J Gastroenterol 18(6):507–516
doi: 10.3748/wjg.v18.i6.507
Wiklander OP, Nordin JZ, O'Loughlin A, Gustafsson Y, Corso G, Mager I, Vader P, Lee Y, Sork H, Seow Y et al (2015) Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting. J Extracell Vesicles 4:26316
doi: 10.3402/jev.v4.26316
Wen SW, Sceneay J, Lima LG, Wong CS, Becker M, Krumeich S, Lobb RJ, Castillo V, Wong KN, Ellis S et al (2016) The biodistribution and immune suppressive effects of breast cancer-derived exosomes. Cancer Res 76(23):6816–6827
doi: 10.1158/0008-5472.CAN-16-0868
Kreimer S, Belov AM, Ghiran I, Murthy SK, Frank DA, Ivanov AR (2015) Mass-spectrometry-based molecular characterization of extracellular vesicles: lipidomics and proteomics. J Proteome Res 14(6):2367–2384
doi: 10.1021/pr501279t
Gangoda L, Liem M, Ang CS, Keerthikumar S, Adda CG, Parker BS, Mathivanan S (2017) Proteomic profiling of exosomes secreted by breast cancer cells with varying metastatic potential. Proteomics 17:23–24
doi: 10.1002/pmic.201600370
Eisenblatter M, Ehrchen J, Varga G, Sunderkotter C, Heindel W, Roth J, Bremer C, Wall A (2009) In vivo optical imaging of cellular inflammatory response in granuloma formation using fluorescence-labeled macrophages. J Nucl Med 50(10):1676–1682
doi: 10.2967/jnumed.108.060707
Lassailly F, Griessinger E, Bonnet D (2010) “Microenvironmental contaminations” induced by fluorescent lipophilic dyes used for noninvasive in vitro and in vivo cell tracking. Blood 115(26):5347–5354
doi: 10.1182/blood-2009-05-224030
Pulaski BA, Ostrand-Rosenberg S. Mouse 4T1 breast tumor model. Curr Protoc Immunol 2001;Chapter 20:Unit 20 2
Paiva AE, Lousado L, Guerra DAP, Azevedo PO, Sena IFG, Andreotti JP, Santos GSP, Goncalves R, Mintz A, Birbrair A (2018) Pericytes in the premetastatic niche. Cancer Res 78(11):2779–2786
doi: 10.1158/0008-5472.CAN-17-3883
Wang X, Cui Y, Luo G, Wang Q, Hu J, He W, Yuan J, Zhou J, Wu Y, Sun X et al (2012) Activated mouse CD4(+)Foxp3(−) T cells facilitate melanoma metastasis via Qa-1-dependent suppression of NK-cell cytotoxicity. Cell Res 22(12):1696–1706
doi: 10.1038/cr.2012.128
Maimela NR, Liu S, Zhang Y (2019) Fates of CD8+ T cells in tumor microenvironment. Comput Struct Biotechnol J 17:1–13
doi: 10.1016/j.csbj.2018.11.004
Doak GR, Schwertfeger KL, Wood DK (2018) Distant relations: macrophage functions in the metastatic niche. Trends Cancer 4(6):445–459
doi: 10.1016/j.trecan.2018.03.011

Auteurs

Mirjam Gerwing (M)

Institute of Clinical Radiology, University Hospital Münster, Münster, Germany.

Vanessa Kocman (V)

Institute of Clinical Radiology, University Hospital Münster, Münster, Germany.

Miriam Stölting (M)

Institute of Clinical Radiology, University Hospital Münster, Münster, Germany.

Anne Helfen (A)

Institute of Clinical Radiology, University Hospital Münster, Münster, Germany.

Max Masthoff (M)

Institute of Clinical Radiology, University Hospital Münster, Münster, Germany.

Johannes Roth (J)

Institute for Immunology, University Muenster, Muenster, Germany.
DFG Cluster of Excellence EXC 1003 'Cells in Motion', Muenster, Germany.

Katarzyna Barczyk-Kahlert (K)

Institute for Immunology, University Muenster, Muenster, Germany.

Lilo Greune (L)

ZMBE, Institute of Infectiology, University Münster, Muenster, Germany.

M Alexander Schmidt (MA)

DFG Cluster of Excellence EXC 1003 'Cells in Motion', Muenster, Germany.

Walter Heindel (W)

Institute of Clinical Radiology, University Hospital Münster, Münster, Germany.

Cornelius Faber (C)

Institute of Clinical Radiology, University Hospital Münster, Münster, Germany.
DFG Cluster of Excellence EXC 1003 'Cells in Motion', Muenster, Germany.

Simone König (S)

IZKF Core Unit Proteomics, University of Muenster, Muenster, Germany.

Moritz Wildgruber (M)

Institute of Clinical Radiology, University Hospital Münster, Münster, Germany.
DFG Cluster of Excellence EXC 1003 'Cells in Motion', Muenster, Germany.
Klinik und Poliklinik für Radiologie, Klinikum der Universität München, Munich, Germany.

Michel Eisenblätter (M)

Institute of Clinical Radiology, University Hospital Münster, Münster, Germany. michel.eisenblaetter@uniklinik-freiburg.de.
Department of Diagnostic and Interventional Radiology, University Hospital Freiburg, University of Freiburg Medical Center, Hugstetter St. 55, 79106, Freiburg im Breisgau, Germany. michel.eisenblaetter@uniklinik-freiburg.de.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH